No problem! The OTC Markets allow cannabis companies to publicly list on their exchange even tho cannabis sales are against US federal law. In Canada, they have the CSE and TSX Venture exchanges which also allow US operating cannabis companies. Many cannabis companies founded in and operating in the US choose to go public via the CSE. The CSE has a reputation for this and is alternatively known as the Cannabis Stock Exchange. Many of these US MSOs simultaneously list on the OTC as well, which is why TCNNF, CRLBF, CURLF, GTBIF, DXBRF etc all end in "F" for foreign even tho they are US companies operating in the US.
The TSX, NASDAQ and NYSE have strict requirements to be included on their exchanges. One requirement is the company must 100% obey federal laws where they operate. Even tho cannabis is legal in select US states it still remains federally illegal. The US doesn't even have a federal medical marijuana policy like Germany, Poland, Australia etc. Cannabis is 100% federally legal in Canada so these Canadian LPs can list on any of the major exchanges and reap all the rewards. These LPs can obtain export and import licenses to ship to/from other 100% legal countries. But they can not export product out of Canada into a US state until the US federally legalizes. And it's gotta be full legalization(modification to the CSA) to get federal laws changed. None of the Canadian LPs are selling THC products in the US. And if they could, they'd have to replicate their operations in each state they operate in. Since US cannabis policy isn't federally legal, interstate commerce isn't allowed. They'd have to apply for licenses and approvals in every individual state they operate in. To prepare for all this, Canopy has a contract to buy Acreage if/when the US changes policy. Aphria bought a US beer company. Cronos/Gotham Green had MedMen. So for all these reasons, US MSOs have a jump on Canadian LPs in terms of the US market but Canadian LPs have the global advantage.
Also, the genetics are worth millions. Peace Naturals has a catalog of genetics from the early days of Canada's medical program(ACMPR). Cronos basically paid nothing for them. For these legal markets, genetics are supposed to be tracked and valued. Cronos had a settlement judgment in their favor against Canopy years back involving genetic valuations of mother plants that died. Genetics are everything in the legal cannabis business. I've heard great things about Cronos' Cove and Spinach brands on r/theOCS.
